Literature DB >> 31049263

Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature.

Austin S Nakatsuka1, Hossein Nazari Khanamiri1, Quy N Lam1, Jaafar El-Annan1.   

Abstract

A 43-year-old male with a history of allergic rhinitis on chronic intranasal corticosteroids presented with complaints of a "black band" in his right eye visual field. On examination, he had subretinal fluid and lab tests and imaging studies including optical coherence tomography (OCT) and fluorescein angiography (FA) did not show any evidence of inflammatory, degenerative, or malignant process. He was diagnosed with central serous chorioretinopathy (CSCR). Symptoms improved and the subretinal fluid resolved after the discontinuation of intranasal corticosteroid medication. Intranasal corticosteroids are rarely associated with CSCR. Patients and providers should be aware of the potential risk of vision loss caused by intranasal corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31049263      PMCID: PMC6495026     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  14 in total

1.  Central serous chorioretinopathy after inhaled steroid use for post-mycoplasmal bronchospasm.

Authors:  B Fardin; D J Weissgold
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

Review 2.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 3.  Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.

Authors:  Andrew J Kleinberger; Chirag Patel; Ronni M Lieberman; Benjamin D Malkin
Journal:  Laryngoscope       Date:  2011-08-16       Impact factor: 3.325

4.  Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.

Authors:  R Haimovici; E S Gragoudas; J S Duker; R N Sjaarda; D Eliott
Journal:  Ophthalmology       Date:  1997-10       Impact factor: 12.079

5.  Long-term follow-up of central serous chorioretinopathy.

Authors:  C M Gilbert; S L Owens; P D Smith; S L Fine
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

6.  Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.

Authors:  J D Gass; H Little
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

7.  Localized topical steroid use and central serous retinopathy.

Authors:  Lauren Y Chan; Robert S Adam; David N Adam
Journal:  J Dermatolog Treat       Date:  2016-01-29       Impact factor: 3.359

8.  Management of allergic rhinitis: a common part of practice in primary care clinics.

Authors:  D-Y Wang; A Chan; J D Smith
Journal:  Allergy       Date:  2004-03       Impact factor: 13.146

9.  Acute visual loss induced by dexamethasone during neoadjuvant docetaxol.

Authors:  D L Gregory; C D Jones; E R E Denton; A N Harnett
Journal:  Clin Med Oncol       Date:  2008-02-09

10.  Recurrent Central Serous Chorioretinopathy with Dexamethasone Eye Drop used Nasally for Rhinitis.

Authors:  Gunjan Prakash; Jain Shephali; Nath Tirupati; Pandey D Ji
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec
View more
  3 in total

1.  "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.

Authors:  Srinivasan Sanjay; Poornachandra B Gowda; Bhimasena Rao; Deepashri Mutalik; Padmamalini Mahendradas; Ankush Kawali; Rohit Shetty
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-05-14

2.  Diagnostic and Therapeutic Challenges in a Patient with Radiation Retinopathy Complicated by Corticosteroid-Induced Central Serous Chorioretinopathy.

Authors:  Michał Chrząszcz; Natalia Mackiewicz; Weronika Pociej-Marciak; Bożena Romanowska-Dixon; Agnieszka Kubicka-Trząska; Maciej Gawęcki; Izabella Karska-Basta
Journal:  Medicina (Kaunas)       Date:  2022-06-28       Impact factor: 2.948

3.  Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center.

Authors:  Corine Rollema; Eric N van Roon; Corine Ekhart; Florence P A M van Hunsel; Tjalling W de Vries
Journal:  Drugs Real World Outcomes       Date:  2022-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.